APA (7th ed.) Citation

YV, S., S, Z., P, L., C, Z., M, H., F, V., . . . P, V. (2023). Hydroxytyrosol produced by engineered Escherichia coli strains activates Nrf2/HO-1 pathway: An in vitro and in vivo study. Experimental biology and medicine (Maywood, N.J.), 248(18), 1598. https://doi.org/10.1177/15353702231187647

Chicago Style (17th ed.) Citation

YV, Simos, et al. "Hydroxytyrosol Produced by Engineered Escherichia Coli Strains Activates Nrf2/HO-1 Pathway: An in Vitro and in Vivo Study." Experimental Biology and Medicine (Maywood, N.J.) 248, no. 18 (2023): 1598. https://doi.org/10.1177/15353702231187647.

MLA (9th ed.) Citation

YV, Simos, et al. "Hydroxytyrosol Produced by Engineered Escherichia Coli Strains Activates Nrf2/HO-1 Pathway: An in Vitro and in Vivo Study." Experimental Biology and Medicine (Maywood, N.J.), vol. 248, no. 18, 2023, p. 1598, https://doi.org/10.1177/15353702231187647.